Compare CRBU & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
Current Price
| Metric | CRBU | NEN |
|---|---|---|
| Founded | 2011 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 239.3M |
| IPO Year | 2021 | N/A |
| Metric | CRBU | NEN |
|---|---|---|
| Price | $1.79 | $65.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 3.3K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.33 |
| Revenue | $9,295,000.00 | ★ $87,362,592.00 |
| Revenue This Year | $8.06 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.22 |
| Revenue Growth | N/A | ★ 7.63 |
| 52 Week Low | $0.66 | $65.00 |
| 52 Week High | $3.54 | $84.00 |
| Indicator | CRBU | NEN |
|---|---|---|
| Relative Strength Index (RSI) | 37.01 | 29.60 |
| Support Level | $1.72 | $66.00 |
| Resistance Level | $1.97 | $71.07 |
| Average True Range (ATR) | 0.15 | 0.95 |
| MACD | -0.01 | -0.39 |
| Stochastic Oscillator | 11.21 | 0.00 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.